Literature DB >> 15913611

Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis.

Zhaoyang Li1, Yong Xiong, Yu Peng, Ji'an Pan, Yu Chen, Xiaoyun Wu, Snawar Hussain, Po Tien, Deyin Guo.   

Abstract

RNA interference (RNAi), a sequence-specific RNA degradation mechanism mediated by small interfering RNA (siRNA), can be used not only as a research tool but also as a therapeutic strategy for viral infection. We demonstrated that intracellular expression of short hairpin RNA (shRNA) targeting human cyclin T1 (hCycT1), a cellular factor essential for transcription of messenger and genomic RNAs from the long terminal repeat promoter of provirus of human immunodeficiency virus type 1 (HIV-1), could effectively suppress the replication of HIV-1. We also showed that downregulation of hCycT1 did not cause apoptotic cell death, therefore, targeting cellular factor hCycT1 by shRNAs may provide an attractive approach for genetic therapy of HIV-1 infection in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913611     DOI: 10.1016/j.febslet.2005.04.074

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis.

Authors:  Musarat Ishaq; Jiajie Hu; Xiaoyun Wu; Qiong Fu; Yalin Yang; Qingzhen Liu; Deyin Guo
Journal:  Mol Biotechnol       Date:  2008-02-08       Impact factor: 2.695

2.  Induction of interleukins IL-6 and IL-8 by siRNA.

Authors:  E Pauls; J Senserrich; M Bofill; B Clotet; J A Esté
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

3.  Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes.

Authors:  Karen Chiang; Tzu-Ling Sung; Andrew P Rice
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

4.  HIV-1 replication and latency are regulated by translational control of cyclin T1.

Authors:  Mainul Hoque; Raghavendra A Shamanna; Deyu Guan; Tsafi Pe'ery; Michael B Mathews
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

Review 5.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

6.  Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant.

Authors:  Guozhen Gao; Xiaoyun Wu; Jieqiong Zhou; Mingfeng He; Johnny J He; Deyin Guo
Journal:  J Biol Chem       Date:  2013-04-08       Impact factor: 5.157

7.  Construction of an artificial MicroRNA expression vector for simultaneous inhibition of multiple genes in mammalian cells.

Authors:  Tao Hu; Qiong Fu; Ping Chen; Li Ma; Onsam Sin; Deyin Guo
Journal:  Int J Mol Sci       Date:  2009-05-14       Impact factor: 6.208

8.  Designing siRNA that distinguish between genes that differ by a single nucleotide.

Authors:  Dianne S Schwarz; Hongliu Ding; Lori Kennington; Jessica T Moore; Janell Schelter; Julja Burchard; Peter S Linsley; Neil Aronin; Zuoshang Xu; Phillip D Zamore
Journal:  PLoS Genet       Date:  2006-07-24       Impact factor: 5.917

9.  Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs.

Authors:  Wendong Yu; Yan Wang; Chad A Shaw; Xiao-Feng Qin; Andrew P Rice
Journal:  Retrovirology       Date:  2006-06-09       Impact factor: 4.602

Review 10.  RNAi therapy for HIV infection: principles and practicalities.

Authors:  Yamina Bennasser; Man Lung Yeung; Kuan-Teh Jeang
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.